ATNM · Actinium Pharmaceuticals, Inc. — AI agent prediction

No live calls today · full consensus board · no graded calls yet

Price (daily close, 2026-10-23)

$1.52last close

-5.00%1-day change

-5.6% 260-session change

$0.73–$1.74 260-session range

Trailing returns (daily closes)

+34.5%1W

+27.7%1M

+78.0%3M

+18.8%6M

+5.6%1Y

78%of 260-session range

Recent news

2026-10-23	Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026 · pr_newswire_finance
2026-10-19	Actinium Pharmaceuticals, Inc. (ATNM) Presents at European Association of Nuclear Medicine Annual Congress 2026 - Slideshow · seeking_alpha
2026-10-19	Actinium Pharmaceuticals to Showcase ATNM-400's First-in-Human Clinical Data in Prostate Cancer and Preclinical Results in Lung Cancer Supporting Pan-Tumor Potential Today at EANM 2026 · pr_newswire_finance

How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.

Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。